Clinical trials
Phase 2/3 trials in Ireland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 7 |
| Active, not recruiting | 6 |
| Terminated | 4 |
| Unknown status | 3 |
| Enrolling by invitation | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Washington University School of Medicine | 3 |
| Ascendis Pharma Growth Disorders A/S | 2 |
| Atlantia Food Clinical Trials | 2 |
| Bristol-Myers Squibb | 2 |
| PENTA Foundation | 2 |
| University College Cork | 2 |
| AbbVie | 1 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Austin Health | 1 |
| Bambino Gesù Hospital and Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 4 |
| Alzheimer Disease | 3 |
| Dementia | 3 |
| Achondroplasia | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Aspergillosis | 1 |
| Brain Neoplasms | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| COVID-19 | 1 |
| Camurati-Engelmann Syndrome | 1 |
Trials
Showing 26 to 39 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.